Diagnostics player Thyrocare Technologies December quarter consolidated net profit remained flat at Rs 14.74 crore.
The company reported a profit of Rs 14.70 crore in the same period last year.
Revenue came in at Rs 134.7 crore, up 5.2 percent from the year-ago quarter, Thyrocare Technologies said in an exchange filing on February 1.
The company's normalised earnings before interest, taxes, depreciation and amortisation (EBITDA) stood at Rs 34.3 crore, up from Rs 32.3 crore in the year-ago period.
The normalised EBITDA margin came at 26 percent against 27 percent last year. The decline was mainly on account of an increase in marketing spends.
Pathology revenue grew 5 percent YoY, while the revenue from franchise grew by 11 percent. Partnerships (excluding API & B2G) grew by 33 percent.
Revenue from wholly owned subsidiary NHL declined 6 percent YoY on account of machine breakdown and low yield. Employee Benefit Expenses increased YoY on account of annual increments and QoQ due to actuarial valuation, the company said in a statement.
(This is a developing story, please come back for updates)
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.